Cargando…
Risk Factor and Replacement Therapy Analysis of Pre- and Postoperative Endocrine Deficiencies for Craniopharyngioma
SIMPLE SUMMARY: Although craniopharyngiomas are pathologically defined as benign tumors, their lesions could involve the hypothalamic–pituitary axis and adjacent to several important anatomical structures. Treatment strategies, including surgery and radiation, have a higher risk of damaging these im...
Autores principales: | Cheng, Lidong, Zhu, Hongtao, Wang, Jing, Wu, Sisi, Zhang, Suojun, Wang, Junwen, Shu, Kai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856947/ https://www.ncbi.nlm.nih.gov/pubmed/36672290 http://dx.doi.org/10.3390/cancers15020340 |
Ejemplares similares
-
Safety and effectiveness of recombinant human growth hormone replacement in postoperative craniopharyngioma children
por: Zheng, Zhang-qian, et al.
Publicado: (2013) -
Targeting FGL2 in glioma immunosuppression and malignant progression
por: Ma, Xiaoyu, et al.
Publicado: (2022) -
Endocrine Disorder in Patients With Craniopharyngioma
por: Zhou, Zihao, et al.
Publicado: (2021) -
Clinical Features, Diagnosis, and Treatment of Primary Intraventricular Lymphoma: Insights From a Monocentric Case Series
por: Cheng, Lidong, et al.
Publicado: (2022) -
Factors related to endocrine changes and hormone substitution treatment during pre- and post-operation stages in craniopharyngioma
por: Sun, Fenglei, et al.
Publicado: (2017)